Sign In
Buy BBIO
$65.48
+1.60 (+2.50%)
At Close: Jun 03, 2026
BridgeBio Pharma, Inc. (BBIO) affiliate company QED Therapeutics announced today that patients have been dosed in separate Phase 3 and Phase 2 clinical trials of infigratinib in cancer indications. T
8 Small Biotech ETFs for Investors | Investing News Network
02:55am, Tuesday, 10'th Mar 2020
Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2019 Update
05:51pm, Sunday, 08'th Mar 2020
Halvorsen's 13F portfolio value increased from $19.20B to $21.35B. The number of positions increased from 61 to 66. Viking Global increased Uber Technologies wh
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
BridgeBio Pharma, Inc. Prices Upsized Offering of $475 Million Convertible Senior Notes
04:32am, Thursday, 05'th Mar 2020
BridgeBio Pharma, Inc. (BBIO) (the “Company,” “we” or “BridgeBio”) announced today the pricing of $475 million aggregate principal amount of 2.50% convertible senior notes due 2027 (the �
CORRECTED-IFR US ECM Calendar
02:42pm, Wednesday, 04'th Mar 2020
(Corrects for timing on CB pricings throughout)
BridgeBio Pharma, Inc. Announces Proposed Offering of $350 Million Convertible Senior Notes
12:00pm, Wednesday, 04'th Mar 2020
BridgeBio Pharma, Inc. (BBIO) (the “Company,” “we” or “BridgeBio”) announced today that it intends to offer, subject to market conditions and other factors, $350 million aggregate princip
BridgeBio Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Portfolio Progress
01:29pm, Monday, 02'nd Mar 2020
-Achieved multiple clinical and pre-clinical milestones across BridgeBio’s pipeline -Delivered pipeline expansion with addition of five new drug development and discovery.
Griekenland en Italië zijn nu veilige havens
12:00am, Monday, 02'nd Mar 2020
Forex Analyses door Cor Wijtvliet (Cor Wijtvliet) over: . Lees Cor Wijtvliet (Cor Wijtvliet)'s Forex Analyses op Investing.com.
Mizuho Securities Keeps Their Buy Rating on BridgeBio Pharma (BBIO)
12:42pm, Saturday, 29'th Feb 2020
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on BridgeBio Pharma (BBIO – Research
Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE) and BridgeBio Pharma (BBIO)
09:12am, Wednesday, 26'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fate Therapeutics (FATE) and BridgeBio Pharma (BBIO) with
Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (NASDAQ: FATE) and BridgeBio Pharma (NASDAQ: BBIO)
09:12am, Wednesday, 26'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fate Therapeutics
